In the case of iShares Biotechnology, the RSI reading has hit 27.6 — by comparison, the RSI reading for the S&P 500 is currently 38.4. A bullish investor could look at IBB's 27.6 reading as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side.
Looking at a chart of one year performance (below), IBB's low point in its 52 week range is $123.60 per share, with $150.565 as the 52 week high point — that compares with a last trade of $124.49. iShares Biotechnology shares are currently trading down about 2.5% on the day.
Find out what 9 other oversold stocks you need to know about »
Also see:
S&P 500 Components Hedge Funds Are Buying Top Ten Hedge Funds Holding TWIO
SPVM Dividend History
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
